Search

everythinglearnresearchcommunity

for

Search:↓

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Alopecia areata involves immune response and gene changes affecting hair loss.

Hormone imbalances from endocrine diseases can cause various skin conditions that help diagnose and treat these diseases early.

A woman with acne and baldness was found to have a rare ovarian condition but successfully had a child through fertility treatment.

Diagnosing alopecia areata is challenging and requires careful examination and various tests to distinguish it from other hair loss types.

A multidisciplinary approach is crucial for effectively managing hair loss linked to endocrine and gynecological disorders.

A patient with total hair loss developed vitiligo after using a treatment called DCP.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

Alopecia Areata is an unpredictable autoimmune hair loss condition with limited and variable treatment effectiveness.

Adrenal disorders can cause lasting brain and behavior issues in children.

A new AIRE gene mutation causes rare autoimmune symptoms in a Lebanese boy.

Generalized vitiligo in Chinese patients is linked to other autoimmune diseases, especially in familial cases.

The review shows that skin symptoms like chronic fungal infections, hair loss, and skin depigmentation are key for early detection and management of APECED.

Some treatments for autoimmune hair loss work, but JAK inhibitors like tofacitinib are promising for regrowth.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

People with hair loss conditions may also have thyroid disorders, but more research is needed to understand the connection.

Alopecia Areata causes hair loss and needs treatments that address both physical and emotional health.

Alopecia areata is an autoimmune disease causing hair loss, treatable with immune-modulating drugs, and linked to genetics.

Treating H. pylori infection might help cure alopecia areata.

Pediatric endocrinologists should provide early fertility counseling and preservation options to young patients at risk of infertility.

Adult acne is often related to hormonal disorders, especially in women, and may need long-term treatment involving specialists.

Alopecia areata patients should have eye check-ups due to increased risk of eye problems.

Certain genes on chromosomes 6, 10, 16, and 18 may increase the risk of alopecia areata.

Scientists are still unsure what triggers the immune system to attack hair follicles in Alopecia areata.

Vitiligo affects overall health and self-esteem, needing more research and awareness.

Some skin problems can be signs of diabetes or other metabolic diseases and recognizing them can help diagnose and treat these diseases early.

The document explains various skin conditions and their treatments.

The document concludes that parathyroid diseases have a range of clinical features and outcomes, with some conditions being treatable and others having a high risk of mortality.

The document is a detailed medical reference on skin and genetic disorders.